Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
2 Visninger
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
Vis mere
Facebook kommentarer
Ingen kommentarer fundet